Indoleamine-2,3-dioxygenase and Interleukin-6 associated with tumor response to neoadjuvant chemotherapy in breast cancer.

about

Indoleamine-2,3-dioxygenase and Interleukin-6 associated with tumor response to neoadjuvant chemotherapy in breast cancer.

Item

http://www.wikidata.org/entity/Q47157830

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Indoleamine-2,3-dioxygenase an ...... chemotherapy in breast cancer.

@en

Indoleamine-2,3-dioxygenase an ...... chemotherapy in breast cancer.

@nl

type

Item

label

Indoleamine-2,3-dioxygenase an ...... chemotherapy in breast cancer.

@en

Indoleamine-2,3-dioxygenase an ...... chemotherapy in breast cancer.

@nl

prefLabel

Indoleamine-2,3-dioxygenase an ...... chemotherapy in breast cancer.

@en

Indoleamine-2,3-dioxygenase an ...... chemotherapy in breast cancer.

@nl

P1476

Indoleamine-2,3-dioxygenase an ...... chemotherapy in breast cancer.

@en

P2093

Fangxuan Li

http://www.w3.org/2001/XMLSchema#string

Juntian Liu

http://www.w3.org/2001/XMLSchema#string

Lijuan Wei

http://www.w3.org/2001/XMLSchema#string

Shixia Li

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative chemotherapy for women with operable breast cancer

GATA-3 transcriptional imprinting in Th2 lymphocytes: a mathematical model

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells

Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR.

Association between adjuvant regional radiotherapy and cognitive function in breast cancer patients treated with conservation therapy.

The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma.

Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy.

Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells.

P304

107844-107858

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.22253

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29296206

http://www.w3.org/2001/XMLSchema#string

P932

5746108

http://www.w3.org/2001/XMLSchema#string